ASH 2016: Cutaneous T-Cell Lymphoma Treatment News


On location at the 2016 American Society of Hematology (ASH) meeting, Dr. Steven Horwitz of Memorial Sloan Kettering Cancer Center explores new and emerging treatments for cutaneous T-cell lymphoma, including the results of the ALCANZA Trial. Dr. Horwitz provides an overview of the disease and shares advice for discussing a new treatment approach with your physician.

Sponsored by Seattle Genetics.

Sign in or Register to view comments.